Investor FAQs

Where is Aimmune Therapeutics located?
Our corporate offices are located at 8000 Marina Boulevard, Suite 200, Brisbane, California 94005-1884
When was Aimmune founded?
The company was founded on June 24, 2011 as Allergen Research Corporation (ARC), a Delaware corporation. In May 2015, we changed our name to Aimmune Therapeutics, Inc.
What is Aimmune’s CUSIP number?
Our CUSIP number is 00900T 107.
On what stock exchange and under what symbol are Aimmune’s shares traded? When did the company go public?
Aimmune is listed on the Nasdaq Global Select Market under the ticker symbol AIMT. Our initial public offering (IPO) was on August 5, 2015.
How can someone buy or sell shares of Aimmune’s stock?
Investors may purchase Aimmune’s stock through a licensed securities broker. We do not offer a direct purchase plan for investors.
Who is Aimmune’s transfer agent?

Aimmune’s transfer agent is Wells Fargo Shareowner Services.
Wells Fargo Shareowner Services
P.O. Box 64874
St. Paul, MN 55164-0874
(800) 468-9716 Toll-Free
(651) 450-4064 Outside of the United States
www.shareowneronline.com

Who do I contact regarding lost stock certificates, address changes, and changes of ownership or name in which shares are held?

Please contact our transfer agent, Wells Fargo Shareowner Services.
Wells Fargo Shareowner Services
P.O. Box 64874
St. Paul, MN 55164-0874
(800) 468-9716 Toll-Free
(651) 450-4064 Outside of the United States
www.shareowneronline.com

Does Aimmune issue dividends on its common stock?
Aimmune does not pay cash dividends on its common stock.
Who are Aimmune’s independent auditors?

Our independent auditors are KPMG LLP.
KPMG LLP
55 2nd Street Suite 1400
San Francisco, CA 94105
(415) 963-5100
www.kpmg.com

Who is Aimmune’s outside legal counsel?

Our outside legal counsel is Latham & Watkins LLP.
Latham & Watkins LLP
140 Scott Drive
Menlo Park, CA 94025
(650) 328-4600
www.lw.com

When is Aimmune’s fiscal year-end?
Our fiscal year-end is December 31.
How can I contact Aimmune for any additional questions?
Please submit an inquiry via our contact form.